GUTTATE PSORIASIS: CLINICAL FEATURES, DIAGNOSIS, AND TREATMENT APPROACHES

ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 1462 GUTTATE PSORIASIS: CLINICAL FEATURES, DIAGNOSIS, AND TREATMENT APPROACHES Abdurakhmanov Akhrorbek Avazbek ugli Senior Lecturer, Department of Dermatovenerology, ASMI ORCID - https://orcid.org/0000-0001-8284-6509 Abstract. Guttate psoriasis is an acute variant of psoriasis characterized by a sudden “shower” of small, drop-like erythematous papules and thin plaques, most often distributed over the trunk and proximal limbs. It commonly affects children and young adults and is frequently triggered by infection—classically streptococcal pharyngitis—appearing about 1–2 weeks after an upper respiratory episode. Diagnosis is usually clinical, supported by dermoscopy and, when needed, biopsy. Because streptococcal infection can act as a trigger, evaluation may include throat culture and/or serologic markers (e.g., ASO, anti–DNase B) to document recent infection. Kеywоrds: guttate psoriasis, streptococcal infection, dermoscopy, differential diagnosis, narrowband UVB. INTRОDUСTIОN Psoriasis is a chronic, immune-mediated inflammatory skin disease with multiple clinical phenotypes. Guttate psoriasis (GP) is distinguished by its abrupt onset and numerous small lesions that resemble scattered “raindrops.” In many patients—especially children and young adults—it is the first presentation of psoriasis, sometimes following an infection. MАTЕRIАLS АND MЕTHОDS Most GP episodes can be managed without systemic agents, but severe, persistent, or highly symptomatic cases may require dermatologist-directed systemic therapy. Guidelines discussing psoriasis management include systemic non-biologic options and note that some systemic retinoids may be used for certain psoriasis subtypes, including guttate presentations, depending on clinical context and specialist oversight. Biologic therapies are generally reserved for more chronic, severe, or refractory psoriasis phenotypes, but clinical reality is nuanced: if GP evolves into chronic plaque psoriasis or substantially impacts quality of life, escalation may be considered by specialists. RЕSULTS АND DISСUSSIОN Beyond its “drop-like” visual impression, guttate psoriasis has a morphology that can shift subtly over time. Early lesions may appear as faint, erythematous macules or small papules with minimal surface change, then gradually develop a delicate, powdery scale as epidermal turnover accelerates. This evolving texture is clinically useful: the scale often becomes more appreciable when the skin is gently stretched or examined under angled light, and it tends to be thinner than in established plaque psoriasis. Lesions typically remain relatively small, yet in some patients they coalesce into irregular thin plaques, creating transitional patterns that can confuse the clinician—especially if the eruption is already several weeks old and the edges are less sharply demarcated. Distribution is also more than a simple “trunk and limbs” statement. Many patients show a trunkdominant scatter with density over the back, flanks, and abdomen, while proximal extremities may demonstrate a peppered arrangement around the shoulders and thighs. Flexural accentuation is not a ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 1463 hallmark, but inverse involvement can occur, particularly when friction, sweating, or secondary irritation contributes to local inflammation. Scalp involvement may be subtle: rather than thick plaques, one may observe fine scaling or scattered erythematous points along the hairline. Nails are usually less prominent in acute guttate outbreaks, but the presence of nail pitting or onycholysis— when found—can hint at a broader psoriatic diathesis and may carry prognostic weight. Itching in guttate psoriasis is often underestimated. Patients may describe intermittent pruritus that fluctuates with stress, heat, or xerosis. Even when pruritus is mild, the widespread visibility of the rash can impose significant psychosocial strain, especially in adolescents and young adults. Clothing choices, social interactions, and sleep may be affected, not because the condition is medically dangerous, but because it is persistently “on display.” For clinical practice and for academic writing, it is important to treat this as real morbidity rather than a cosmetic footnote. The patient’s quality of life can deteriorate despite a seemingly “benign” cutaneous course, and symptom-guided treatment often matters as much as lesion clearance. Where clinical morphology becomes ambiguous, dermoscopy can provide supportive clues. Guttate psoriasis often demonstrates a vascular pattern consistent with psoriatic inflammation—commonly punctate or regularly distributed vessels—along with diffuse background erythema and superficial scaling. While dermoscopy is not a substitute for clinical reasoning, it can reduce diagnostic uncertainty in early or atypical presentations and can help distinguish psoriasis-like eruptions from certain papulosquamous mimickers that display different vascular arrangements. Histopathology, when pursued, typically shows changes aligned with psoriatic biology: parakeratosis and acanthosis, diminished granular layer, and inflammatory cell migration into the epidermis. Microabscesses and spongiform pustules can be found in psoriatic processes, though their prominence varies with lesion age and sampling site. Importantly, biopsy is most helpful not when psoriasis is already obvious, but when the clinician must confidently exclude alternatives that require different management or carry different public-health implications [1]. Laboratory testing should be tailored to a clinical question rather than performed as a ritual. In guttate psoriasis, the key question is often whether there is an ongoing or recent infection acting as a trigger and whether that infection needs treatment for its own sake. When throat symptoms are present, targeted evaluation for bacterial pharyngitis can be reasonable. Serologic markers may support the notion of recent streptococcal exposure, but they do not automatically dictate dermatologic escalation; they are best interpreted as pieces of a timeline rather than as “proof” that antibiotics will clear the eruption. In patients with atypical features or systemic symptoms, broader testing can be justified. For example, when the rash is unusually persistent, severe, or accompanied by constitutional signs, one must consider whether immune status, medication exposures, or alternative diagnoses are contributing. Here, the thoughtful clinician behaves like a detective: tests are ordered to answer a clear differential diagnosis, not to decorate the chart [2]. Several papulosquamous disorders can masquerade as guttate psoriasis. Pityriasis rosea often follows a characteristic sequence and can exhibit lesions oriented along cleavage lines, sometimes preceded by a solitary “herald patch.” Its scaling pattern is frequently described as a collarette, differing from the more diffuse psoriatic scale. Tinea corporis, particularly when disseminated or partially treated, can mimic small plaques, but tends to show annular configuration with central clearing and a more ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 1464 active border; mycologic evaluation becomes important when the pattern, exposure history, or lack of response to anti-inflammatory therapy suggests dermatophytosis. Secondary syphilis is a classic mimicker that deserves explicit mention in academic writing because missing it carries consequences beyond dermatology. Its eruption can be widespread, may involve palms and soles, and can be accompanied by systemic signs. The key lesson is methodological: guttate psoriasis should be diagnosed confidently, but not casually—especially when the clinical picture is “too perfect” or the patient’s history introduces red flags [3]. Even when guttate psoriasis is expected to resolve, severity grading is valuable for two reasons: it guides therapy selection and it creates an objective baseline for follow-up. Estimation of body surface area involvement, symptom scoring (pruritus, burning, sleep disruption), and patient-reported outcomes help clinicians rationally choose between topical-only management and phototherapy or systemic escalation. In an academic article, this section is where you can show clinical maturity: severity is not just what the doctor sees; it is also what the patient experiences. Management in guttate psoriasis benefits from a tiered approach. The foundation is barrier support. Widespread inflammation is amplified by dryness and microfissuring, so emollients are not merely cosmetic—they reduce irritant susceptibility and can decrease itch-scratch cycles that perpetuate inflammation. Gentle skin care, temperature moderation, and avoidance of aggressive exfoliation contribute to a calmer cutaneous environment that improves responsiveness to active therapy [4]. Topical anti-inflammatory agents remain central, but their application requires nuance. Because guttate lesions are numerous and often widespread, practicality matters: a regimen that is theoretically perfect but impossible to execute will fail. Short courses of appropriately selected topical corticosteroids can control inflammation, while steroid-sparing agents may be considered for sensitive areas where long-term steroid use is undesirable. Vitamin D analogs and combination regimens may enhance efficacy in some cases, but irritation and adherence must be considered— especially when the rash covers large surface areas. In many real-world settings, the best regimen is the one the patient can actually do twice a day without resenting you. Phototherapy occupies a special position in guttate psoriasis because it can treat extensive disease efficiently and tends to provide a favorable balance between effectiveness and tolerability when delivered under clinical supervision. The mechanism aligns with immunomodulation at the skin level, dampening inflammatory pathways and reducing hyperproliferation. Proper patient selection is essential, including assessment of photosensitivity risks, prior skin cancers, and the feasibility of frequent clinic visits [5]. СОNСLUSIОN Guttate psoriasis is a distinctive acute psoriasis phenotype marked by rapid onset of numerous small, scaly papules—often following streptococcal infection. Diagnosis is mainly clinical, supported by targeted evaluation for streptococcal triggers when appropriate. Treatment is guided by severity and extent: topical therapy and emollients for limited disease; NB-UVB phototherapy is a mainstay for widespread involvement; antibiotics treat active strep infections but do not consistently resolve the cutaneous eruption. Many cases clear within months, yet a meaningful minority progress to chronic plaque psoriasis, warranting follow-up and trigger management. RЕFЕRЕNСЕS 1. Elmets C.A., Lim H.W., Stoff B. et al. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with ISSN: 2582-4686 SJIF 2021-3.261,SJIF 20222.889, 2024-6.875 ResearchBib IF: 9.948 / 2024 VOLUME-5, ISSUE-12 1465 phototherapy // Journal of the American Academy of Dermatology. – 2019. – Vol. 81, No. 3. – P. 775–804. Scholars@Duke 2. Dupire G., Droitcourt C., Hughes C., Le Cleach L. Antistreptococcal interventions for guttate and chronic plaque psoriasis // Cochrane Database of Systematic Reviews. – 2019. – Issue 3. – Art. No. CD011571. – DOI: 10.1002/14651858.CD011571.pub2. PubMed 3. Owen C.M., Chalmers R.J., O’Sullivan T., Griffiths C.E. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis // British Journal of Dermatology. – 2001. – Vol. 145, No. 6. – P. 886–890. – DOI: 10.1046/j.1365-2133.2001.04504.x. PubMed 4. Chalmers R.J.G., O’Sullivan T., Owen C.M., Griffiths C.E.M. A systematic review of treatments for guttate psoriasis // British Journal of Dermatology. – 2001. – Vol. 145, No. 6. – P. 891– 894. – DOI: 10.1046/j.1365-2133.2001.04505.x. OUP Academic 5. Zhou T., Koussiouris J., Kim L., Vender R. Management of Guttate Psoriasis: A Systematic Review // Journal of Cutaneous Medicine and Surgery. – 2024. – Vol. 28, No. 6. – P. 577–584. – DOI: 10.1177/12034754241266187. PubMed